Introduction: overview of animal models for focal segmental glomerulosclerosis
Classic animal models for FSGS
Renal ablation model
Model | Mechanism | Method | Phenotype | Strain(S/R) | |
---|---|---|---|---|---|
Hyperfiltration due to reduced number of nephrons | 5/6 nephrectomy | Proteinuria within 1 week of ablation | Most Rat 129 Sv mouse | C57BL/6 mouse | |
Toxin: premature chain termination during ribosomal protein translation | Mild: 50 mg/kg single IV/Severe: 10 mg/kg with additional 40 mg/kg every 4 weeks | Massive proteinuria within 10 days | Most Rat | PVGc rat Most mouse | |
Toxin: DNA intercalation and inhibition of macromolecular biosynthesis | 2 mg/kg twice with 3 week interval | Massive proteinuria, hypercholesterolemia, hypertension, anemia, azotemia within 16 weeks | Most Rat BALB/C, 129sVj, 129s1/sVimj, BALB/CbY mouse | C57BL6/J, FVB/NJ, CAST/EiJ, AKR/J, C3H/HeJ, CBA/J, C57BL/10J, LP/J, SWR/J, SJL/J, 129S6/SvEvTac mouse | |
Circulating factors | Spontaneous | Proteinuria on 3rd to 4th month of age | Rat | – | |
Hyperfiltration due to decreased nephron number | Spontaneous | Albuminuria at 8 week | Male rat | – | |
Direct podocyte toxicity | Mouse with hCD25 receptor on podocyte/LMB2 (0.625 ng/g) | Progressive nonselective proteinuria, ascites, and edema | C57BL6 | – | |
Diphtheria toxin [37] | Direct podocyte toxicity | diphtheria toxin receptor on podocyte/ DT (10 ml/g) injection | Progressive nonselective proteinuria, ascites, and edema | Rat | – |
Virus host response | Transfection fertilized eggs of a hybrid between C57BL/6 and DBA/2 with Vpr and the nephrin gen promoter | Collapsing FSGS | C57BL/6 DBA/2 | ||
Direct podocyte damage | Injection human–mouse Thy-1.1 in zygotes of Thy-1.2 CBA X C57BI mice | Proteinuria, FSGS | C57BI CBA |
Induction of FSGS using podocyte-toxic drugs
Puromycin aminonucleoside
Adriamycin model
Models with spontaneous FSGS
Buffalo/MWF model
Munich-Wistar-Fromter rat
NEP25 mouse model
Diphtheria toxin model
HIV-nephropathy model
Thy-1.1 transgenic mouse model
New genetically engineered mouse models for FSGS
Actin cytoskeleton
α-Actinin 4 model
Animal model | Human model | Affected location |
---|---|---|
α-Actinin-4 [45] | Actin filament cross-linking protein/Interacts with integrins and strengthens the podocyte-GBM interaction | |
Tight junctions/Formation of Par complex and interacts with slit diaphragm | ||
Rhophilin-1 [80] | Rho GTPase activating protein 24 [80] | Cytoplasm/Rho GTPase-interacting protein, integrity of glomerular filtration barrier |
Membrane/pseudocyst formation at podocyte | ||
CD2-associated protein [64] | Insertion site of the slit diaphragm/Formation SD complex with podocin and nephrin | |
Podocyte anchoring and differentiation in GBM | ||
Cytoplasm/Inhibition of expression of WT-1 | ||
Actin binding long-tailed motor protein/Regulation of actin cytoskeleton | ||
Membrane/the activation of calcineurin-NFAT/Wnt signaling via the increased calcium influx | ||
Podocin [46] | Insertion site of the SD/SD assembly and maintaining the signaling of nephrin | |
Actin filament development/glomerular sclerosis | ||
Transcription factor 21(Pod1) [78] | Cytoplasm/Development of endothelial and mesangial cell | |
SD/Planar cell polarity signaling pathway for morphogenesis | ||
Wilms tumor suppressor 1 [79] | Downregulation of nephrin and synaptopodin |